Updates in the Management of Pediatric and Adult Brain Tumors

Updates and Controversies in the Treatment of Pediatric and Adult Brain Tumor is planned and implemented interprofessionally by physicians and nurses. It is designed for these professions who specialize in Neurosurgery, Pediatric Neurosurgery, Pediatric Neuro-Oncology, and Medical Oncology including pediatric hematologists oncologists, medical oncologists, and neurosurgeons.

This course may also be of interest to Pediatric and Adult Neuro-Oncologists, Pediatric and Adult Medical Oncologists,  general pediatricians, pediatric neurologists, ER physicians, radiation oncologists, and physician associates. This 6-hour course will provide education through lectures, case based discussions, interactive Q&A sessions, and expert panels. The activity will highlight best practices across Pediatric and Adult Brain Tumor treatment. The goal of this activity is to enhance knowledge and patient care.

Social Event:
Join Us for an Exciting Night of Cardinals Baseball as the St. Louis Cardinals take on the Los Angeles Dodgers at Busch Stadium! Complimentary shuttle service from Chase Park Plaza to Busch Stadium and back.

Event Details:
Date: May 1, 2026
Pick Up Time: 6pm 
Game Time:  7:15 PM
Shuttle Pick Up/ drop off Location: Chase Park Plaza- Lindell Side, 212 N Kingshighway Blvd St. Louis, MO 63108
Game: Busch Stadium 700 Clark Avenue St. Louis, MO 63102
Teams: St. Louis Cardinals vs. Los Angeles Dodgers

Tickets are available for purchase [here]

Grab your tickets now and be part of the excitement at Busch Stadium!

Go Cardinals!

1. State the prognostic and therapeutic implications of molecular subtypes of adult and pediatric brain tumors
2. Describe the latest advances and controversies in pediatric and adult brain tumor treatment.
3. Apply evidence based strategies in surgery, radiation, and emerging therapies to optimize patient care.
4. Collaborate effectively within multidisciplinary teams to improve treatment planning and outcomes.
5. Integrate personalized approaches to enhance patient centered care and quality of life.

Fees includes enrollment, continuing education credits, educational materials, continental breakfast, lunch and refreshment breaks, day of parking (paid registrants only).

*** IMPORTANT NOTE for Employees of industry (e.g., pharmaceutical & device companies): DO NOT REGISTER HERE. Please email [email protected] for pre-approval for attendance at this course. Should you register without pre-approval, your registration will be cancelled and refunded less a $25 administrative fee.

Registration/Payment Policy: Your full payment in advance completes your registration and ensures your enrollment in this course. 

Cancellations: Registration fee less $25 administrative charge is refundable if cancellation is received in writing by emailing [email protected] by April 15, 2026. Registration fees are not transferable.

Minimum and Maximum Enrollments Have Been Established.
Please Note: Washington University is not responsible for airline, hotel reservations or any other travel expenses. Please confirm registration acceptance prior to purchase of non-refundable or penalty airline tickets.

Transportation:
•    Taxis from the airport are approximately $40.
•    Uber and Lyft are also available.  

In support of improving patient care, Washington University School of Medicine in St. Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The cancellation cut-off dates and fees are specific to each course. Refer to the cancellation policy on the individual course page. Please send cancellation requests to [email protected].

WashU Medicine CME reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs incurred, such as non-refundable airline tickets or hotel penalties.

Continuing Medical Education at Washington University School of Medicine fully complies with the legal requirements of the Americans with Disabilities Act rules and regulations thereof. If any participant of this meeting is in need of accommodations, please do not hesitate to submit written requests, at least one month prior to seminar date.

Suggested Hotel Accommodations: 

The Chase Park Plaza Royal Sonesta St. Louis
212 N Kingshighway Blvd, St. Louis, MO 63108
Make your hotel reservations directly with the hotel.
WashU Rate: $191 + tax
Cut-Off date April 9, 2026
Online:https://book.passkey.com/go/WashURoomBlock
By phone: Reservations phone number is 314-633-3300

Doubletree by Hilton St. Louis Forest Park 
Adjacent to the conference center:
4550 Forest Park Ave., St. Louis, MO 63110
Make your hotel reservations directly with the hotel:
Ask for the Washington University Visitor rate.
Online at  Book your hotel Enter Code #3209101 under “special rate corporate”
By phone at 314-256-7777

Home 2 Suites by Hilton St. Louis/ Forest Park
920 S. Taylor Avenue, St. Louis, MO 63110
Make your hotel reservations directly with the hotel:
Online: Book your hotel
By phone: Reservations phone number is 314-531-4446

Please Note: Washington University is not responsible for airline, hotel reservations or any other travel expenses. Please confirm registration acceptance prior to purchase of nonrefundable or penalty airline tickets.

Transportation:
•    Taxis from the airport are approximately $40.
•    Uber and Lyft are also available.
•    MetroLink runs from the airport to the Medical Center
     (Central West End Station) for approximately $4.00.

Washington University School of Medicine in St. Louis School of Medicine adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Mitigation of Relevant Financial Relationships

Washington University School of Medicine in St. Louis adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including Faculty, planners, reviewers, or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Megan Goldberg, BA
Office Manager IV
Washington University
St. Louis, MO

Activity Administrator

Nothing to disclose

Whitney Kemper, MHA
Washington University
St. Louis, MO

Activity Administrator

Nothing to disclose

Ashley Vaughn
St. Louis Children's Hospital
St. Louis, MO

Activity Administrator

Nothing to disclose

Mohamed S Abdelbaki, MD
Director, Neuro-Oncology Program
Washington University School of Medicine in St. Louis
St. Louis, MO

Co-Director, Faculty

Grant or research support-Blueprint Medicines Corp|Grant or research support-Day One Biopharmaceuticals|Grant or research support-Public Health Institute/PHI|Other relevant financial or material interests-Day One Biopharmaceuticals (*)|Speakers Bureau-Day One Biopharmaceuticals (*)|Speakers Bureau-Ipsen Biopharmaceuticals Inc (*)

Tanner M Johannes, MD, PhD
Assistant Professor of Medicine,
Washington University School of Medicine
St. Louis, MO

Co-Director, Faculty

Grant or research support-Adaptimmune Limited|Grant or research support-Alpheus Medical Inc|Grant or research support-Altor BioScience Corporation|Grant or research support-AstraZeneca AB (Sweden)|Grant or research support-AstraZeneca Pharmaceuticals LP|Grant or research support-BeOne Medicines (formerly BeiGene Ltd)|Grant or research support-Bristol Myers Squibb Co/BMS|Grant or research support-Cardinal Health LLC|Grant or research support-Compass Therapeutics LLC|Grant or research support-Denovo Biopharma|Grant or research support-Genentech Inc|Grant or research support-Geneos Therapeutics Inc|Grant or research support-Gritstone Oncology|Grant or research support-IDEAYA Biosciences|Grant or research support-Immunocore|Grant or research support-IN8Bio|Grant or research support-Incyte Corporation|Grant or research support-Iovance Biotherapeutics Inc|Grant or research support-Lentigen Technology, Inc.|Grant or research support-Oncovir Inc|Grant or research support-PapiVax Biotech US Inc|Grant or research support-Prelude Therapeutics|Grant or research support-RAPT Therapeutics|Grant or research support-Replimune Inc|Grant or research support-Servier Pharmaceuticals LLC|Other relevant financial or material interests-Servier Pharmaceuticals LLC|Other relevant financial or material interests-Servier Pharmaceuticals LLC (*)

Albert H. Kim, MD, PhD
Washington University School of Medicine
St. Louis, MO

Course Director, Faculty

Grant or research support-Collagen Matrix|Grant or research support-Glioblastoma Foundation|Grant or research support-Monteris Medical|Other relevant financial or material interests-Monteris Medical Inc|Royalties or Patent Beneficiary-Grace Medical Inc. (*)

Eric M Thompson, MD
Professor of Neurosurgery, Pediatrics, and Cell Biology & Physiology
Washington University
St. Louis, MO

Course Director, Faculty

Grant or research support-Bristol Myers Squibb Co/BMS|Other relevant financial or material interests

Nicole Brossier, MD, PhD
Assistant Professor, Pediatric Hematology/Oncology
Washington University in St. Louis
Saint Louis, MO

Faculty

Grant or research support-MD Anderson Cancer Center|Grant or research support-Novartis Pharmaceuticals Corporation|Other relevant financial or material interests-Aptitude Health (*)|Other relevant financial or material interests-market Plus (*)|Other relevant financial or material interests-SpringWorks Therapeutics Inc|Other relevant financial or material interests-SpringWorks Therapeutics Inc (*)

Omar H Butt, MD,
Instructor in Medicine
WUSM
St Louis, MO

Faculty

Grant or research support-Incyte Corporation|Grant or research support-Novocure Inc.|Grant or research support-Nuvation Bio Inc|Other relevant financial or material interests-Novocure Inc.|Speakers Bureau-Menarini Silicon Biosystems|Other relevant financial or material interests-Novocure Inc. (*)|Speakers Bureau-Menarini Silicon Biosystems (*)

Milan G. Chheda, MD
Washington University
St. Louis, MO

Faculty

Grant or research support-Guidehouse, Inc|Grant or research support-Incyte Corporation|Grant or research support-Orbus Therapeutics, Inc.|Other relevant financial or material interests-American Brain Tumor Association/ABTA (*)|Other relevant financial or material interests-Florida Department of Health|Other relevant financial or material interests-guidepoint network (*)|Other relevant financial or material interests-Health Advances LLC (*)|Other relevant financial or material interests-National Institutes of Health Center for Scientific Review (*)|Other relevant financial or material interests-Not Found 2 (*)|Other relevant financial or material interests-Telix Pharmaceuticals Ltd|Other relevant financial or material interests-UpToDate (*)|Other relevant financial or material interests-UpToDate, Inc. (*)|Other relevant financial or material interests-Not Found 2|Other relevant financial or material interests-Florida Department of Health (*)|Other relevant financial or material interests-Telix Pharmaceuticals Ltd (*)

Andrew S. Cluster, MD
Washinton University in St. Louis
St. Louis, MO

Faculty

Other relevant financial or material interests|Grant or research support-Turning Point Therapeutics Inc|Grant or research support-EMD Serono Inc|Grant or research support-Oncoceutics, Inc.|Grant or research support-PapiVax Biotech US Inc|Grant or research support-Chimerix Inc|Grant or research support-Fennec Pharmaceuticals|Grant or research support-Public Health Institute/PHI

Mai Dang, MD
Washington University
Saint Louis, MO

Faculty

Nothing to disclose

Peter Dirks, MD, PhD

Faculty

Jiayi Huang, MD
WUSM
St. Louis, MO

Faculty

Grant or research support-BostonGene Corporation|Grant or research support-Cantex Pharmaceuticals|Speakers Bureau-Baptist Health South Florida|Speakers Bureau-University of Missouri (Relationship has ended)|Speakers Bureau-Baptist Health South Florida (*)

Michael Huang, MD, MS
Associate Professor
Washington University in St. Louis
St. Louis, MO

Faculty

Grant or research support-Beat Childhood Cancer Consortium/BCCC|Grant or research support-Day One Biopharmaceuticals|Other relevant financial or material interests

Eric Leuthardt, MD
WUSM
St. Louis, MO

Faculty

Grant or research support-DePuy Synthes|Grant or research support-DIXI Medical|Grant or research support-Health Resources in Action/HRIA|Grant or research support-Monteris Medical|Grant or research support-Neurolutions|Other relevant financial or material interests-ACERA (*)|Other relevant financial or material interests-Aurenar LLC|Other relevant financial or material interests-Inflexion Vascular LLC|Other relevant financial or material interests-Inner Cosmos|Other relevant financial or material interests-Monteris (*)|Other relevant financial or material interests-Neuroloutions, Inc. (*)|Other relevant financial or material interests-Petal Surgical (*)|Other relevant financial or material interests-Sora Imaging Solutions (*)|Ownership-ACERA (*)|Ownership-Aurenar LLC|Ownership-Cordance Medical (*)|Ownership-Inflexion Vascular LLC|Ownership-Inner Cosmos|Ownership-Neuroloutions, Inc. (*)|Ownership-Petal Surgical (*)|Ownership-Sileng Surgical (*)|Ownership-Sora Imaging Solutions (*)|Ownership-SympEL Neuromodulation (*)|Royalties or Patent Beneficiary-Aurenar LLC|Royalties or Patent Beneficiary-Cordance Medical (*)|Royalties or Patent Beneficiary-Inner Cosmos|Royalties or Patent Beneficiary-Neuroloutions, Inc. (*)|Royalties or Patent Beneficiary-Sora Imaging Solutions (*)|Stocks or stock options, excluding diversified mutual funds*-red devil 4 (*)|Other relevant financial or material interests-Aurenar LLC (*)|Other relevant financial or material interests-Inflexion Vascular LLC (*)|Other relevant financial or material interests-Inner Cosmos (*)|Ownership-Aurenar LLC (*)|Ownership-Inflexion Vascular LLC (*)|Ownership-Inner Cosmos (*)|Royalties or Patent Beneficiary-Aurenar LLC (*)|Royalties or Patent Beneficiary-Inner Cosmos (*)

Dimitrios Mathios, MD
Dr
Washington University in St Louis
St Louis, MO

Faculty

Royalties or Patent Beneficiary-Delfi Diagnostics|Royalties or Patent Beneficiary-Johns Hopkins University|Royalties or Patent Beneficiary-Delfi Diagnostics (*)|Royalties or Patent Beneficiary-Johns Hopkins University (*)

Michelle M Miller-Thomas, MD
Professor
Mallinckrodt Institute of Radiology
St. Louis, MO

Faculty

Nothing to disclose

Bhuvic Patel, MD
Washington University in St. Louis
St. Louis, MO

Faculty

Nothing to disclose

Stephanie Perkins, MD
Washington University
St. Louis, MO

Faculty

Nikhil Rammohan, MD, PhD
Washington University School of Medicine
Saint Louis, MO

Faculty

Other relevant financial or material interests-Servier Pharmaceuticals LLC|Other relevant financial or material interests-Servier Pharmaceuticals LLC (*)

Josh B. Rubin, MD
Professor
SLCH
St. Louis, MO

Faculty

Grant or research support-Turning Point Therapeutics Inc|Other relevant financial or material interests

Katherine Schwetye, MD, PhD
Associate Professor
Washington University
Clayton, MO

Faculty

Nothing to disclose

Julie Silverstein, MD
Professor of Medicine and Neurological Surgery
WashU School of Medicine
CLAYTON, MO

Faculty

Advisor-Camurus (Relationship has ended)|Advisor-Chiesi (Relationship has ended)|Advisor-XERIS PHARMACEUTICALS (Relationship has ended)

Ashley Meyer, MSN, RN
Washington University
Troy, IL

Faculty, Other Planning Committee Member, Peer Reviewer

Nothing to disclose

Friday, May 1, 2026

This activity may be supported in part by educational grants from various commercial organizations. A complete list of commercial supporters will be available at the time of the conference. Some companies may also exhibit.

This activity may be supported in part by educational grants from various commercial organizations. A complete list of commercial supporters will be available at the time of the conference. Some companies may also exhibit.

Platinum Level

Gold Level

Silver Level

Bronze Level

If you are a company and would like to exhibit or provide an educational grant for this educational program,
please contact Stacy Partrich at [email protected]